The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Mycobutin 150mg Hard Capsules



Pfizer Healthcare IrelandPA0822/109/001

Main Information

Trade NameMycobutin 150mg Hard Capsules
Active SubstancesRifabutin
Dosage FormCapsule, hard
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/109/001

Group Information

ATC CodeJ04AB Antibiotics
J04AB04 rifabutin

Status

License statusAuthorised
Licence Issued12/01/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back